A kind of phloroglucinol compound and its application in the preparation of antibacterial drugs
A technology for phloroglucinol and antibacterial drugs, applied to phloroglucinol compounds and the application field in preparing antibacterial drugs, can solve problems such as insufficient research and achieve low eukaryotic cell toxicity, significant antibacterial activity, active effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Extraction, separation and structural identification of the compound of Example 1
[0031] (1) Take 8 kg of dried myrtle branches and leaves, pulverize them into coarse powder, extract 4 times by percolation with 95% (w / w) ethanol, each 25 L, combine the percolation liquid and concentrate under reduced pressure to no alcohol smell, The obtained total extract is about 1.2kg. The extract was suspended with water and then extracted with petroleum ether to obtain 389 g of petroleum ether extraction fractions.
[0032] (2) Carry out silica gel column chromatography on the petroleum ether extraction part prepared in step (1), using petroleum ether-ethyl acetate as eluent, according to the volume ratio of petroleum ether and ethyl acetate is 100:0, 100:1 , 100:3, 100:5, 100:7, 100:10, 100:30, 100:50, 100:100 and 0:100 elution gradients were eluted, analyzed by thin layer chromatography (TLC) and combined Similar fractions were obtained to obtain 10 main fractions Fr.1-Fr.10....
Embodiment 2
[0048] The inhibitory effect of embodiment 2 (+) Myrtucyclitones A-B and (-) Myrtucyclitones A-B to various bacteria
[0049] Staphylococcus aureus S.aureus ATCC29213, methicillin-resistant Staphylococcus aureus S.aureusATCC33591 (MRSA), vancomycin-intermediate resistant Staphylococcus aureus S.aureus Mu50 (VISA), Staphylococcus epidermidis S.epidermidis ATCC12228, E. faecalis ATCC29212, E. faecium 13-01, Escherichia coli ATCC25922, Ps. aeruginosa Ps. Aeruginosa, all from the Institute of Pharmaceutical Biotechnology, Chinese Academy of Medical Sciences.
[0050] The minimum inhibitory concentration (MIC) of the compound's antibacterial effect in vitro was determined by the broth micro-doubling dilution method, and the specific operation method was as follows:
[0051] (1) Bacterial culture: Cultivate the experimental bacteria with Mueller-Hinton (MH) broth medium, when it grows for 8-12h to about 0.5 Mcfarland concentration (1 × 10 8 CFU) for backup.
[0052] (2) Dissolve t...
Embodiment 3
[0058] The influence of embodiment 3 (+) Myrtucyclitones A-B and (-) Myrtucyclitones A-B on normal cells
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com